Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1779, doi. 10.1038/mt.2009.133
- By:
- Publication type:
- Article
Works matching IS 15250016 AND DT 2009 AND VI 17 AND IP 10
Results: 26
1
2
Effect of VEGF on the Regenerative Capacity of Muscle Stem Cells in Dystrophic Skeletal Muscle.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1788, doi. 10.1038/mt.2009.136
- By:
- Publication type:
- Article
3
Corrigendum to “Gene Therapy for Diabetes: Metabolic Effects of Helper-dependent Adenoviral Exendin 4 Expression in a Diet-induced Obesity Mouse Model”.
- Published in:
- 2009
- Publication type:
- Correction Notice
4
Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1743, doi. 10.1038/mt.2009.141
- By:
- Publication type:
- Article
5
Biosafety in Ex Vivo Gene Therapy and Conditional Ablation of Lentivirally Transduced Hepatocytes in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1754, doi. 10.1038/mt.2009.143
- By:
- Publication type:
- Article
6
Conditions for Tumor-free and Dopamine Neuron–enriched Grafts After Transplanting Human ES Cell–derived Neural Precursor Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1761, doi. 10.1038/mt.2009.148
- By:
- Publication type:
- Article
7
Influence of Coagulation Factor X on In Vitro and In Vivo Gene Delivery by Adenovirus (Ad) 5, Ad35, and Chimeric Ad5/Ad35 Vectors.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1683, doi. 10.1038/mt.2009.152
- By:
- Publication type:
- Article
8
Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1814, doi. 10.1038/mt.2009.154
- By:
- Publication type:
- Article
9
Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1724, doi. 10.1038/mt.2009.156
- By:
- Publication type:
- Article
10
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1799, doi. 10.1038/mt.2009.157
- By:
- Publication type:
- Article
11
Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1733, doi. 10.1038/mt.2009.159
- By:
- Publication type:
- Article
12
Coadministration of Telomerase Genetic Vaccine and a Novel TLR9 Agonist in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1804, doi. 10.1038/mt.2009.165
- By:
- Publication type:
- Article
13
In Vivo Myogenic Potential of Human CD133<sup>+</sup> Muscle-derived Stem Cells: A Quantitative Study.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1771, doi. 10.1038/mt.2009.167
- By:
- Publication type:
- Article
14
Phase I Study of H5.020CMV.PDGF-β to Treat Venous Leg Ulcer Disease.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1822, doi. 10.1038/mt.2009.169
- By:
- Publication type:
- Article
15
A Novel Estrogen Receptor Intramolecular Folding–based Titratable Transgene Expression System.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1703, doi. 10.1038/mt.2009.171
- By:
- Publication type:
- Article
16
Efficient Gene Delivery and Selective Transduction of Glial Cells in the Mammalian Brain by AAV Serotypes Isolated From Nonhuman Primates.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1692, doi. 10.1038/mt.2009.170
- By:
- Publication type:
- Article
17
Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1712, doi. 10.1038/mt.2009.176
- By:
- Publication type:
- Article
18
Corrigendum to “Regulation of Adult Hematopoietic Stem Cells Fate for Enhanced Tissue-specific Repair”.
- Published in:
- 2009
- Publication type:
- Correction Notice
19
Erratum to “Influence of Coagulation Factor X on In Vitro and In Vivo Gene Delivery by Adenovirus (Ad) 5, Ad35, and Chimeric Ad5/Ad35 Vectors”.
- Published in:
- 2009
- Publication type:
- Correction Notice
20
Targeting Cancer-initiating Cells With Oncolytic Viruses.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1677, doi. 10.1038/mt.2009.193
- By:
- Publication type:
- Article
21
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1667, doi. 10.1038/mt.2009.194
- By:
- Publication type:
- Article
22
Adenovirus Virion Stability and the Viral Genome: Size Matters.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
23
Correction and Apology.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
24
In This Issue.
- Published in:
- 2009
- Publication type:
- Abstract
25
Research Highlights.
- Published in:
- 2009
- Publication type:
- Abstract
26
Translating Stem Cell Therapy to the Clinic: Déjà Vu All Over Again.
- Published in:
- 2009
- By:
- Publication type:
- Editorial